Gengraf (Cyclosporine Capsules, Modified) and Insulin glargine and lixisenatide
Determining the interaction of Gengraf (Cyclosporine Capsules, Modified) and Insulin glargine and lixisenatide and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: cyclosporine
Brand name: Gengraf, Neoral, Sandimmune, Sandimmune
Synonyms: Gengraf (Capsules, Modified), Gengraf
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin Glargine and Lixisenatide
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Gengraf (Cyclosporine Capsules, Modified)-Insulin glargine and lixisenatide Subcutaneous
- Gengraf (Cyclosporine Capsules, Modified)-Insulin glargine, recombinant Subcutaneous
- Gengraf (Cyclosporine Capsules, Modified)-Insulin glulisine
- Gengraf (Cyclosporine Capsules, Modified)-Insulin Glulisine (Cartridges and Pens)
- Gengraf (Cyclosporine Capsules, Modified)-Insulin Glulisine (Vials)
- Gengraf (Cyclosporine Capsules, Modified)-Insulin glulisine Subcutaneous
- Insulin glargine and lixisenatide-Gengraf (Cyclosporine Oral Solution, Modified)
- Insulin glargine and lixisenatide-Gengraf Capsules
- Insulin glargine and lixisenatide-Gengraf Oral
- Insulin glargine and lixisenatide-Gengraf Oral Solution
- Insulin glargine and lixisenatide-Genicin
- Insulin glargine and lixisenatide-Genicin Vita-Q